Search research articles
Contact Us
Filters
Showing results (91-100 of 113) with videos related to
Page
of 12
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
October 22, 2017
A comparative study of warheads for design of cysteine protease inhibitors
Daniel G Silva, Jean F R Ribeiro, Daniela De Vita, et al.
Acta Psychiatrica Scandinavica
|
January 26, 2017
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C A Köhler, T H Freitas, M Maes, et al.
Molecules (Basel, Switzerland)
|
August 7, 2013
Amazonian plant natural products: perspectives for discovery of new antimalarial drug leads
Adrian Martin Pohlit, Renata Braga Souza Lima, Gina Frausin, et al.
Materials (Basel, Switzerland)
|
February 24, 2024
Micro-Addition of Silver to Copper: One Small Step in Composition, a Change for a Giant Leap in Biocidal Activity
Vitor G Vital, Márcio R Silva, Vinicius T Santos, et al.
Molecular Neurobiology
|
June 15, 2017
Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, et al.
Plos One
|
June 21, 2011
An essential nuclear protein in trypanosomes is a component of mRNA transcription/export pathway
Mariana Serpeloni, Carolina Borsoi Moraes, João Renato Carvalho Muniz, et al.
Morphologie : Bulletin De L'Association Des Anatomistes
|
November 19, 2018
Anatomical study of length and branching pattern of main trunk of the left coronary artery
O Pereira da Costa Sobrinho, J Dantas de Lucena, R Silva Pessoa, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
July 21, 2020
Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity
Caio H Franco, David C Warhurst, Tapan Bhattacharyya, et al.
European Journal of Medicinal Chemistry
|
February 7, 2018
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections
Pasquale Linciano, Carolina B Moraes, Laura M Alcantara, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 2022
Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi <i>In Vitro</i> and <i>In Vivo</i>
Ramendra P Pandey, Marilda Savoia Nascimento, Caio Haddad Franco, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 113) with videos related to
Sort By:
Page
of 12
Bioorganic & Medicinal Chemistry Letters
|
October 22, 2017
A comparative study of warheads for design of cysteine protease inhibitors
Daniel G Silva, Jean F R Ribeiro, Daniela De Vita, et al.
Acta Psychiatrica Scandinavica
|
January 26, 2017
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C A Köhler, T H Freitas, M Maes, et al.
Molecules (Basel, Switzerland)
|
August 7, 2013
Amazonian plant natural products: perspectives for discovery of new antimalarial drug leads
Adrian Martin Pohlit, Renata Braga Souza Lima, Gina Frausin, et al.
Materials (Basel, Switzerland)
|
February 24, 2024
Micro-Addition of Silver to Copper: One Small Step in Composition, a Change for a Giant Leap in Biocidal Activity
Vitor G Vital, Márcio R Silva, Vinicius T Santos, et al.
Molecular Neurobiology
|
June 15, 2017
Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, et al.
Plos One
|
June 21, 2011
An essential nuclear protein in trypanosomes is a component of mRNA transcription/export pathway
Mariana Serpeloni, Carolina Borsoi Moraes, João Renato Carvalho Muniz, et al.
Morphologie : Bulletin De L'Association Des Anatomistes
|
November 19, 2018
Anatomical study of length and branching pattern of main trunk of the left coronary artery
O Pereira da Costa Sobrinho, J Dantas de Lucena, R Silva Pessoa, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
July 21, 2020
Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity
Caio H Franco, David C Warhurst, Tapan Bhattacharyya, et al.
European Journal of Medicinal Chemistry
|
February 7, 2018
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections
Pasquale Linciano, Carolina B Moraes, Laura M Alcantara, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 2022
Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi <i>In Vitro</i> and <i>In Vivo</i>
Ramendra P Pandey, Marilda Savoia Nascimento, Caio Haddad Franco, et al.
Page
of 12